SMYD5 and neoplasm: This consistent upregulation of SMYD5 in both LIHC tumor tissues and cell lines (HepG2 and Hep3B) relative to the normal hepatic stellate cell line LX-2 (Figure 3c) underscores its potential role as a promoter of hepatocarcinogenesis.